ZANELLATI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 973
EU - Europa 771
AS - Asia 582
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.329
Nazione #
US - Stati Uniti d'America 954
CN - Cina 507
IE - Irlanda 246
UA - Ucraina 150
FI - Finlandia 127
DE - Germania 103
SG - Singapore 54
SE - Svezia 50
IT - Italia 35
GB - Regno Unito 26
CA - Canada 19
FR - Francia 11
CZ - Repubblica Ceca 8
IR - Iran 7
GR - Grecia 5
IN - India 5
JP - Giappone 4
BE - Belgio 3
CH - Svizzera 2
PK - Pakistan 2
AT - Austria 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
NL - Olanda 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.329
Città #
Dublin 246
Chandler 217
Jacksonville 188
Nanjing 134
Beijing 73
New York 66
Ashburn 64
Helsinki 58
Nanchang 54
Boardman 52
Changsha 48
Singapore 44
Hebei 38
Lawrence 35
Medford 35
Princeton 35
Shenyang 35
Wilmington 31
Jiaxing 26
Tianjin 25
Hangzhou 18
Shanghai 18
Toronto 14
Dearborn 9
Pavia 9
Ann Arbor 8
Norwalk 8
Brno 7
Falkenstein 7
Los Angeles 6
Milan 6
Munich 6
Washington 6
Woodbridge 6
Jinan 5
Kunming 5
Verona 5
Henderson 4
Leawood 4
London 4
Ningbo 4
Tokyo 4
Zhengzhou 4
Fairfield 3
Ottawa 3
Sacramento 3
Bassano del Grappa 2
Bologna 2
Brussels 2
Chicago 2
Fuzhou 2
Gunzenhausen 2
Mumbai 2
Naples 2
Pune 2
Seattle 2
Taizhou 2
Zanjan 2
Alessandria 1
Andover 1
Athens 1
Auburn Hills 1
Berlin 1
Bolton 1
Borås 1
Chennai 1
Des Moines 1
Frankfurt am Main 1
Guayaquil 1
Haikou 1
Islamabad 1
Jinzhou 1
Kyjov 1
Lanzhou 1
Monmouth Junction 1
Newark 1
Orange 1
Piscataway 1
Rechthalten 1
Rockville 1
Shijiazhuang 1
Tallinn 1
Tappahannock 1
Turin 1
Winnipeg 1
Wuhan 1
Zurich 1
Totale 1.733
Nome #
Induzione e mantenimento di remissione clinica mediante l’utilizzo di Budesonide in paziente affetto da malattia di Crohn ad esordio giovanile, a localizzazione ileo-colonica e fenotipo steno-fistolizzante, già sottoposto a terapia immunosoppressiva, biologica, cellulare e chirurgica. 101
Clinical response to gluten withdrawal is not an indicator of coeliac disease. 95
Immunosuppressive effect of bone marrow-derived mesenchymal stromal cells on gliadin-specific T cell lines 90
A one minute questionnaire to evaluate the compliance to a gluten-free diet. 83
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 79
Are anti-actin antibodies useful for coeliac disease diagnosis?. 76
The incidence of coeliac disease in adult first degree relatives. 75
Coeliac disese in first degree relatives: an incidence study 74
Treatment of fistulizing Crohn’s disease with local infusions of autologus bone marrow-derived mesenchymal stromal cells 73
Clinical response to gluten withdrawal is not an indicator of coeliac disease. 73
Effects of Infliximab on circulating dendritic cell populations in Crohn’s disease 73
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 73
Interferon therapy for chronic hepatitis virus c infection is not associated to an increased risk to develop coeliac disease 72
Induction of immune tolerance to gluten in coeliac disease after allogeneic haematopoietic stem cell transplantation for thalassaemia major 72
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 72
Italian translation, cultural adaptation and initial statistical validation of the inflammatory bowel disease questionnaire 70
Study of the espression of receptor for advanced glycation end products (RAGE), in inflammatory bowel disease 70
The incidence of coeliac disease in adult first degree relatives 69
Is coeliac disease overdiagnosed? 69
The impact of misdiagnosing celiac disease at a referral centre. 67
Treatment of fistulizing Crohn’s disease with local infusions of autologus bone marrow-derived mesenchymal stromal cells 65
The impact of misdiagnosing celiac disease at a referral centre 64
Plasma levels of soluble receptor for advanced glycation end products inversely correlate with clinical and serological activity indexes in patients with Inflammatory Bowel Disease 61
Induction Of Immune Tolerance To Gluten After Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) For Thalassaemia Major. 61
Bone marrow-derived mesenchymal stromal cells locally injected for refractory fistulizing Crohn’s disease modulate serum immunoglobulins, secretory IgA, and antibody production 60
Expression Of The Soluble Form Of The Receptor For Advanced Glycation End Product (RAGE) In Patients With Inflammatory Bowel Disease (IBD) 60
Decreased Serum Levels Of Soluble Receptor For Advanced Glycation End Product (RAGE) In Patients With Inflammatory Bowel Disease (IBD) 59
Usefulness of antibodies to deamidated gliadin peptides (DGP) in coeliac disease (CD) 55
Clinical Utility Of Antibodies To Deamidated Gliadin Peptides In Coeliac Disease 54
Minimal duodenal lesions in patiens without endomysial antibody 54
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 53
Decreased Serum Levels Of Soluble Receptor For Advanced Glycation End Products Inversely Correlate With Disease Activity Indexes In Patients With Inflammatory Bowel Disease 50
Receptor for advanced glycation end products (RAGE) expression in inflammatory bowel disease (IBD) 40
Reactivation of opportunistic viral infections in inflammatory bowel disease 38
Use Of Autologous Bone Marrow-Derived Mesenchymal Stromal Cells In The Treatment Of Adult Autoimmune Enterophaty. 37
Totale 2.337
Categoria #
all - tutte 8.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020154 0 0 0 0 0 0 15 33 0 71 35 0
2020/2021261 31 28 8 29 0 37 0 36 8 40 36 8
2021/2022154 4 0 12 0 0 1 0 8 8 0 44 77
2022/2023638 60 64 10 35 68 56 0 27 291 10 9 8
2023/2024274 48 32 11 10 22 108 1 13 3 8 6 12
2024/2025155 9 36 32 16 7 52 3 0 0 0 0 0
Totale 2.337